BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24657823)

  • 1. Controlling the droplet size of formulations nebulized by vibrating-membrane technology.
    Beck-Broichsitter M; Knuedeler MC; Seeger W; Schmehl T
    Eur J Pharm Biopharm; 2014 Aug; 87(3):524-9. PubMed ID: 24657823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boosting the aerodynamic properties of vibrating-mesh nebulized polymeric nanosuspensions.
    Beck-Broichsitter M; Knuedeler MC; Oesterheld N; Seeger W; Schmehl T
    Int J Pharm; 2014 Jan; 459(1-2):23-9. PubMed ID: 24286921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the correlation of output rate and aerodynamic characteristics in vibrating-mesh-based aqueous aerosol delivery.
    Beck-Broichsitter M; Oesterheld N; Knuedeler MC; Seeger W; Schmehl T
    Int J Pharm; 2014 Jan; 461(1-2):34-7. PubMed ID: 24291081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulization of active pharmaceutical ingredients with the eFlow(®) rapid: impact of formulation variables on aerodynamic characteristics.
    Beck-Broichsitter M; Prüfer N; Oesterheld N; Seeger W; Schmehl T
    J Pharm Sci; 2014 Aug; 103(8):2585-9. PubMed ID: 24986144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrolyte type and nozzle composition affect the process of vibrating-membrane nebulization.
    Beck-Broichsitter M; Oesterheld N
    Eur J Pharm Biopharm; 2017 Oct; 119():11-16. PubMed ID: 28499855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosol Production by Vibrating Membrane Technology: Analysis of the Electrolyte Effect on Generated Droplet Size and Nebulizer Output Rate.
    Beck-Broichsitter M
    J Pharm Sci; 2017 Aug; 106(8):2168-2172. PubMed ID: 28479359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of tailored aerosols for inhalative drug delivery employing recent vibrating-mesh nebulizer systems.
    Bohr A; Beck-Broichsitter M
    Ther Deliv; 2015; 6(5):621-36. PubMed ID: 26001177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic aging of degradable nanosuspension ameliorates vibrating-mesh nebulizer performance.
    Dalla-Bona AC; Schmehl T; Gessler T; Seeger W; Beck-Broichsitter M
    Drug Dev Ind Pharm; 2015; 41(10):1704-9. PubMed ID: 25519975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of magnetizable aerosols.
    Baumann R; Glöckl G; Nagel S; Weitschies W
    Eur J Pharm Sci; 2012 Apr; 45(5):693-7. PubMed ID: 22306649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of fluid physicochemical properties on vibrating-mesh nebulization.
    Ghazanfari T; Elhissi AM; Ding Z; Taylor KM
    Int J Pharm; 2007 Jul; 339(1-2):103-11. PubMed ID: 17451896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers.
    Beck-Broichsitter M; Kleimann P; Schmehl T; Betz T; Bakowsky U; Kissel T; Seeger W
    Eur J Pharm Biopharm; 2012 Oct; 82(2):272-80. PubMed ID: 22820646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a droplet evaporation model to aerodynamic size measurement of drug aerosols generated by a vibrating mesh nebulizer.
    Rao N; Kadrichu N; Ament B
    J Aerosol Med Pulm Drug Deliv; 2010 Oct; 23(5):295-302. PubMed ID: 20455771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
    Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
    Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
    Nasr M; Najlah M; D'Emanuele A; Elhissi A
    Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the vibrating membrane aerosol generation device: Aeroneb Micropump Nebulizer.
    Zhang G; David A; Wiedmann TS
    J Aerosol Med; 2007; 20(4):408-16. PubMed ID: 18158713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology.
    Elhissi A; Hidayat K; Phoenix DA; Mwesigwa E; Crean S; Ahmed W; Faheem A; Taylor KM
    Int J Pharm; 2013 Feb; 444(1-2):193-9. PubMed ID: 23299083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Making Concentrated Antibody Formulations Accessible for Vibrating-Mesh Nebulization.
    Beck-Broichsitter M
    J Pharm Sci; 2019 Aug; 108(8):2588-2592. PubMed ID: 30885662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Characterization of the eFlow Closed System Nebulizer with Glycopyrrolate Inhalation Solution.
    Pham S; Ferguson GT; Kerwin E; Goodin T; Wheeler A; Bauer A
    J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):162-169. PubMed ID: 29125918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulizers for drug delivery to the lungs.
    Martin AR; Finlay WH
    Expert Opin Drug Deliv; 2015 Jun; 12(6):889-900. PubMed ID: 25534396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.